FCM
CORZ icon

Fieldview Capital Management’s Core Scientific CORZ Stock Holding History

Fieldview Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,014
Closed -$150K – 558
2026
Q1 		$150K Sell
10,014
-19,549
-66% -$333K 0.04% 465
2025
Q4 		$430K Buy
+29,563
New +$515K 0.07% 300

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Fieldview Capital Management's CORZ Position: Q2 2026 in Review

Fieldview Capital Management sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 10,014 shares — an estimated $150K sold.

Fieldview Capital Management first reported a position in CORZ in Q4 2025 and held it in 2 quarters. The position peaked at $430K in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Fieldview Capital Management reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 10,014 Core Scientific shares in Q2 2026, an estimated $150K.
  • Fieldview Capital Management first reported a position in Core Scientific in Q4 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Core Scientific position peaked at $430K in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.